Cleanis Group Innothera


In hospitals, CLEANIS contributes to hygiene and fights against Hospital Acquired Infections (HAIs)

Since the emergence of highly resistant bacteria and new health risks, the management of body fluids, bathing of bedridden patients, or even the safe elimination of fluids have become major issues in the control of infectious risk for institutions.

CLEANIS products, designed and tested in collaboration with hygienists, perfectly respond to these issues. Scientific studies demonstrate their impact in the decreased rate of infections, optimisation of nursing staff and cost reduction for hospitals. Their use is now part of the recommendations and official protocols enacted by many international hygiene and public health organisations.

HAIs (Hospital-Acquired-Infections) represent:

4% of patients hospitalised in the US
More than 1.4 million infected individuals in the world at any given moment

  • US: CDC,
  • Export: OMS,